Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
Payer Medical Policies Can Promote Effective Use of Comprehensive Sequencing In Community Oncology Setting
...
Register
Zika Blood Screening Not Cost-Effective, Study Finds
...
Register
Market Trends: Lab-Retail Collaboration Remains Strong Despite Theranos Debacle
From - Laboratory Industry Report
The Theranos debacle hasn't dissuaded retailers from partnering with labs…
Enforcement Trends: After 2017 Decline, False Claims Act Healthcare Recoveries Bounce Back
From - National Intelligence Report
Although the False Claims Act (FCA) remains a federal enforcement cash cow, the growth rate has fallen off in recent years, at least in the…
Medicare Reimbursement: CMS Provides Needed PAMA Relief—But Newly Covered Hospital Labs Must Report in 2019
From - Lab Compliance Advisor
The battle between CMS and the lab industry over Medicare Part B pricing for lab tests could be on the road to…
Low-Value, Blood Glucose Self-Monitoring is Common
From - Diagnostic Testing & Emerging Technologies
A substantial percentage of patients with type 2 diabetes may be inappropriately self-monitoring blood glucose, according to a research letter published…
Provider Fined for Not Taking Compliance Measures Required by Its CIA
...
Register
Mergers, Acquisitions & Asset Sales Analysis – May 2019
...
Register
Mergers, Acquisitions & Asset Sales Analysis – March 2019
...
Register
Mergers, Acquisitions & Asset Sales Analysis – January 2019
...
Register